Nath Bio-Genes — 360° view

Nath Bio-Genes, a company in the Other Agricultural Products industry, reported revenue of ₹328 crore and net profit of ₹32 crore for the June 2026 quarter.

Nath Bio-Genes (NSE: NATHBIOGEN) closed at ₹132.73 on 20 Nov 2026, down 17.7% over the past year. Its market capitalisation is ₹252 crore and it trades at 7.5 times earnings.

Share price
₹132.73 (20 Nov 2026)
Market cap
₹252 Cr (20 Nov 2026)
P/E
7.45 (20 Nov 2026)
Revenue
₹328 Cr (June 2026 quarter)
Net profit
₹32 Cr (June 2026 quarter)
ROCE
7.16% (FY26)
ROE
5.33% (FY26)
Book value
₹358 (FY26)
Dividend yield
1.51% (last 12 months to 20 Nov 2026)
52-week high / low
₹204.00 / ₹126.15 (20 Nov 2026)
1-year return
-17.7% (to 20 Nov 2026)
Sector
Fast Moving Consumer Goods
Industry
Other Agricultural Products
Symbol
NSE: NATHBIOGEN

Incorporated in 1993, Nath Bio-Genes Ltd is in the business of Production, Processing, and Marketing of Hybrid and GM Seeds

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.